Immunai Raises $60M to Reprogram Immunity
Similar Posts
Belong.Life Raises $14 Million Series B Round to Accelerate Growth of Global Oncology Solution
Funding Helps World’s Largest Cancer Social Network To Advance Platform for Payers, Providers and Life Science Companies, Continued Rollout of…
Beddr to Launch New Solution for Improving Sleep with $5.6 Million in Series A Funding
Pre-orders Start Today for Beddr SleepTuner, An FDA-Listed Product that Leverages a Scientific, Integrated Approach to Understanding and Solving…
Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer’s Disease Treatment in the Home
$10 million funding round led by Openspace Ventures with participation from EDBI will fuel first-in-class virtual neurology clinics Neuroglee…
Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…
Gravie Secures $28 Million in Financing Led by AXA Venture Partners
Gravie, the pioneer of defined contribution healthcare, has completed a $28 million Series D round of financing led by…
